Correction to: Andexanet Alfa: First Global Approval

被引：0
|
作者：
Young-A Heo
机构：
[1] Springer,
来源：
Drugs | 2018年 / 78卷 / 12期
关键词：
D O I：
10.1007/s40265-018-0954-y
中图分类号：
学科分类号：
摘要：
The article Andexanet Alfa: First Global Approval, written by Young-A Heo, was originally published Online First without open access.
引用
收藏
页码：1285 / 1285
相关论文
共 50 条
  • [21] Correction to: Caplacizumab: First Global Approval
    Sean Duggan
    [J]. Drugs, 2018, 78 (18) : 1955 - 1955
  • [22] Andexanet alfa-The first 150 days
    Culbreth, Sarah E.
    Rimsans, Jessica
    Sylvester, Katelyn
    Pallin, Daniel J.
    Connors, Jean M.
    [J]. AMERICAN JOURNAL OF HEMATOLOGY, 2019, 94 (01) : E21 - E24
  • [23] Correction to: Polatuzumab Vedotin: First Global Approval
    Emma D. Deeks
    [J]. Drugs, 2019, 79 (16) : 1829 - 1829
  • [24] Correction to: Moxetumomab Pasudotox: First Global Approval
    Sohita Dhillon
    [J]. Drugs, 2019, 79 (1) : 105 - 105
  • [25] Efbemalenograstim Alfa: First Approval
    Hannah A. Blair
    [J]. Drugs, 2023, 83 : 1125 - 1130
  • [26] Avalglucosidase alfa: First Approval
    Dhillon, Sohita
    [J]. DRUGS, 2021, 81 (15) : 1803 - 1809
  • [27] Apadamtase Alfa: First Approval
    Heo, Young-A.
    [J]. DRUGS, 2024, 84 (03) : 275 - 284
  • [28] Efbemalenograstim Alfa: First Approval
    Blair, Hannah A. A.
    [J]. DRUGS, 2023, 83 (12) : 1125 - 1130
  • [29] Efanesoctocog Alfa: First Approval
    Susan J. Keam
    [J]. Drugs, 2023, 83 : 633 - 638
  • [30] Apadamtase Alfa: First Approval
    Young-A. Heo
    [J]. Drugs, 2024, 84 : 467 - 472
12345